Preface by Snyder, Robert
There have been few opportunities for those who have studied the
benzene problem to convene and conduct a comprehensive review
ofour current understanding ofexposure to benzene, its metabo-
lism, the resulting toxicological and carcinogenic effects, the evalu-
ation ofhuman impacts, and the assessment ofpotential risks due
to benzene exposure. Benzene '95was the first such assembly since
the Symposium on Benzene Metabolism, Toxicity and Carcinogenesis
sponsored by the National Institute of Environmental Health
Sciences in March 1988. In the intervening 7 years, research on
benzene has advanced dramatically, in part due to pressure from
regulators who require better information for setting exposure
standards but, more importantly, because significant advances in
molecular biology and in hematology have permitted us to explore
the effects ofbenzene on the bone marrow with new tools and a
better understanding ofthe physiology ofhematopoiesis. Parallel
developments in physiologically based pharmacokinetics and bio-
mathematical modeling are on the verge ofpermitting us to use
mechanistic data to improve the process of risk assessment. The
large volume of recent data and the discussion of new ideas for
studying the benzene problem demonstrated the need for
Benzene '95 at this time and suggested to the attendees that we
should not wait 7 more years before reconvening.
The program was prepared on the basis of communications
with researchers in the benzene field from around the world.
Speakers and attendees from 14 countries participated in Benzene
'95. Thirty-seven of our colleagues from this country and abroad
supplied suggestions for topics and speakers. Emphasis was placed
on exposure to benzene, benzene metabolism and the generation
of biological reactive intermediates, bone marrow impacts, and
epidemiology ofbenzene-induced leukemia. Concerns regarding
the role ofmyelodysplasia in benzene-induced bone marrow dis-
ease, effects ofbenzene and its metabolites on early events in bone
marrow cell differentiation and proliferation, and production and
effects ofchromosome damage following benzene exposure were
among the highlights of the meeting. Ofparticular interest were
the discussions surrounding attempts to include pharmacokinetic
modeling data in the risk assessment process.
The conference organizing committee included M. Bird
(Exxon Corp.), B.D. Goldstein (Environmental and Occupational
Health Sciences Institute [EOHSI]), G.F. Kalf (Thomas Jefferson
University), H. Kipen (EOHSI), D.L. Laskin (EOHSI), J. Laskin
(EOHSI), M. Linet (National Cancer Institute), C. Mackerer
(Stonybrook Laboratories), C. Weisel (EOHSI), C. Witmer
(EOHSI), and G. Witz (EOHSI). V.B. Leyton was director ofthe
staff and coordinated all logistical functions with a high level of
profession expertise. Kevin Kimberlin was in charge offinancial
affairs. My assistant Bernadine Chmielowicz, put in long hours of
hard work to assure the success ofthe symposium. We also thank
J. Braun and her colleagues in the Office of Continuing and
Professional Education of Rutgers University for their efforts in
making Benzene '95a success.
The conference would not have been possible without financial
assistance from the Environmental and Occupational Health
Sciences Institute, Rutgers, The State University of New Jersey,
the University ofMedicine and Dentistry ofNew Jersey/Robert
Wood Johnson Medical School, and the Joint Graduate Program
in Toxicology. Extramural support was obtained from the
Agency for Toxic Substances and Disease Registry; the American
Petroleum Institute; CONCAWE: The Oil Companies' European
Organization for Environment, Health and Safety, Brussels,
Belgium; the Exxon Corporation, East Millstone, NJ; and the U.S.
Environmental Protection Agency, Research Triangle Park, NC.
We are deeply indebted to our supporters. The wide range of
interests represented at the national and international levels is
testimony to the worldwide significance ofthe benzene problem.
It is important to continually remind our students and
colleagues that science did not begin the day they first stepped into
a laboratory. We must be aware of and be prepared to acknowl-
edge historically significant contributions to our science.
Accordingly, at Benzene '95we took the opportunity to recognize
the contributions ofDennis V. Parke (University ofSurrey) for his
pioneering work on the metabolism of [14C]benzene and
Alessandra Forni (University of Milan) for her research on
benzene-induced chromosome damage, and it is to them that this
volume is dedicated.
ROBERT SNYDER
CHRIRMAN, ORGANIZING COMMITrEE
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